Literature DB >> 17111306

Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression.

D Raaz1, H Wallaschofski, C Stumpf, A Yilmaz, I Cicha, L Klinghammer, W G Daniel, T Lohmann, C D Garlichs.   

Abstract

Prolactin and leptin are newly recognized platelet co-stimulators due to enhancement of ADP-induced platelet aggregation. The aim of our study was to assess whether both hormones prolactin and leptin play a role as co-activators of platelet activation in patients with acute coronary syndromes. Twenty-one patients with acute coronary syndromes, 10 with stable angina pectoris and 10 controls were studied. Patients with acute coronary syndromes showed significantly higher prolactin and leptin values and a significant increased P-selectin expression on platelets compared to patients with stable angina pectoris or controls. However, patients with acute myocardial infarction as a subgroup of acute coronary syndromes showed the highest prolactin levels as well as ADP stimulated P-selectin expression. In the myocardial infarction subgroup prolactin values showed a significant correlation to ADP stimulated P-selectin expression on platelets (r (2)=0.41; p=0.025), whereas leptin was not correlated. Our data indicate an association between increased prolactin values and enhanced P-selectin expression on platelets in patients with acute coronary syndromes. Therefore, the stress hormone prolactin could be a co-stimulator of platelet activation in these patients. In contrast, the putative platelet activator leptin does not seem to play a major role in acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111306     DOI: 10.1055/s-2006-955090

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  A 12-month moderate-intensity exercise intervention does not alter serum prolactin concentrations.

Authors:  Kerryn W Reding; Johanna W Lampe; C Y Wang; Frank Z Stanczyk; Cornelia M Ulrich; Liren Xiao; Catherine R Duggan; Anne McTiernan
Journal:  Cancer Epidemiol       Date:  2011-02-10       Impact factor: 2.984

2.  Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD.

Authors:  Juan Jesús Carrero; John Kyriazis; Alper Sonmez; Ioannis Tzanakis; Abdul Rashid Qureshi; Peter Stenvinkel; Mutlu Saglam; Kostas Stylianou; Halil Yaman; Abdullah Taslipinar; Abdulgaffar Vural; Mahmut Gok; Mujdat Yenicesu; Eugene Daphnis; Mahmut Ilker Yilmaz
Journal:  Clin J Am Soc Nephrol       Date:  2011-12-22       Impact factor: 8.237

3.  Macroprolactinemia, like hyperprolactinemia, may promote platelet activation.

Authors:  Inan Anaforoglu; Melek Eda Ertorer; Ilknur Kozanoglu; Birsel Unal; Filiz Eksi Haydardedeoglu; Okan Bakiner; Emre Bozkirli; Neslihan Bascil Tutuncu; Nilgun Guvener Demirag
Journal:  Endocrine       Date:  2010-02-03       Impact factor: 3.633

4.  Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas.

Authors:  Sann Yu Mon; Abdulrahman Alkabbani; Amir Hamrahian; Julie N Thorton; Lawrence Kennedy; Robert Weil; Leann Olansky; Krupa Doshi; Vinne Makin; Betul Hatipoglu
Journal:  Pituitary       Date:  2013-12       Impact factor: 4.107

5.  Maternal prolactin inhibition during lactation programs for metabolic syndrome in adult progeny.

Authors:  Egberto Gaspar de Moura; Isabela Teixeira Bonomo; José Firmino Nogueira-Neto; Elaine de Oliveira; Isis Hara Trevenzoli; Adelina Martha Reis; Magna Cottini Fonseca Passos; Patricia Cristina Lisboa
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

Review 6.  Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.

Authors:  Carlo Dal Lin; Francesco Tona; Elena Osto
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

7.  The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis.

Authors:  Haiyan Yang; Junbo Di; Jiexue Pan; Rong Yu; Yili Teng; Zhuhua Cai; Xiaohui Deng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-12       Impact factor: 5.555

8.  Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.

Authors:  Haiyan Yang; Jie Lin; He Li; Zhangwei Liu; Xia Chen; Qianqian Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

9.  Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers.

Authors:  Masamichi Ishioka; Norio Yasui-Furukori; Norio Sugawara; Hanako Furukori; Shuhei Kudo; Kazuhiko Nakamura
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-24       Impact factor: 2.570

Review 10.  Prolactin and Autoimmunity.

Authors:  Vânia Vieira Borba; Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.